Tempest Therapeutics, Inc. (TPST) vs Tvardi Therapeutics, Inc. (TVRD)

Tempest Therapeutics, Inc. and Tvardi Therapeutics, Inc. are both Biotechnology companies. Tempest Therapeutics, Inc. and Tvardi Therapeutics, Inc. are of similar size ($14.7M and $14.4M). Tvardi Therapeutics, Inc. grew revenue faster over the last twelve months: −34.4% against −53.0%. Across the 11 metrics below, Tvardi Therapeutics, Inc. leads on 9 and Tempest Therapeutics, Inc. on 2.

Valuation

Metric TPST TVRD Biotechnology median
P/E n/m n/m 7.88
P/S 39.00 1.07 11.47
P/B n/m 1.42 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 52.83 2.42 10.73
Earnings yield (515.66%) (219.69%) (28.84%)
Free cash flow yield (167.50%) (236.42%) (23.03%)

Profitability

Metric TPST TVRD Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (931.14%) (126.19%) (57.72%)
Return on assets (237.25%) (85.08%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric TPST TVRD Biotechnology median
Revenue growth (TTM) (52.98%) (34.36%) 5.64%
EPS growth (last fiscal year) 67.55% 79.51% —
Revenue growth, 5-year CAGR — (18.53%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric TPST TVRD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.38 1.87 4.73
Net debt to EBITDA 0.29 1.15 0.96

Dividend

Metric TPST TVRD Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric TPST TVRD Biotechnology median
Market cap 14.39m 14.67m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack